RE 29 (Glycopyrrolate 2 mg)
Pill imprint RE 29 has been identified as Glycopyrrolate 2 mg.
Glycopyrrolate is used in the treatment of excessive salivation; anesthesia; copd, maintenance; peptic ulcer and belongs to the drug class anticholinergics/antispasmodics. There is no proven risk in humans during pregnancy. Glycopyrrolate 2 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- RE 29
- Strength:
- 2 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Anticholinergics/antispasmodics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Ranbaxy Pharmaceuticals Inc.
More about glycopyrrolate
Consumer resources
- Glycopyrrolate
- Glycopyrrolate solution
- Glycopyrrolate tablets
- Glycopyrrolate inhalation
- Glycopyrrolate (Advanced Reading)
- Other brands: Robinul, Robinul Forte, Cuvposa, Seebri Neohaler, More (1) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
